NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 348 filers reported holding NEKTAR THERAPEUTICS in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,594,000 | -85.6% | 78,915 | -73.3% | 0.57% | -75.2% |
| Q3 2018 | $18,008,000 | +52.4% | 295,405 | +22.1% | 2.30% | +26.2% |
| Q2 2018 | $11,813,000 | -5.5% | 241,922 | +105.6% | 1.82% | +144.6% |
| Q1 2018 | $12,502,000 | +947.1% | 117,662 | +488.3% | 0.75% | +584.4% |
| Q4 2017 | $1,194,000 | +84.3% | 20,000 | -60.4% | 0.11% | +289.3% |
| Q2 2014 | $648,000 | +6.6% | 50,514 | +0.7% | 0.03% | -17.6% |
| Q1 2014 | $608,000 | +10033.3% | 50,177 | +9935.4% | 0.03% | – |
| Q4 2013 | $6,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 750,000 | $930,000 | 0.85% |
| Deep Track Capital, LP | 17,875,498 | $22,165,618 | 0.66% |
| Acuitas Investments, LLC | 879,904 | $1,091,081 | 0.58% |
| TCG Crossover Management, LLC | 4,000,000 | $4,960,000 | 0.52% |
| Almitas Capital LLC | 920,225 | $1,141,079 | 0.47% |
| Monaco Asset Management SAM | 2,166,432 | $2,686,376 | 0.43% |
| Shay Capital LLC | 1,840,377 | $2,282,067 | 0.32% |
| Nantahala Capital Management | 4,110,000 | $5,096,400 | 0.30% |
| Ikarian Capital, LLC | 1,312,405 | $1,627,382 | 0.28% |
| SAMLYN CAPITAL, LLC | 9,457,887 | $11,727,781 | 0.20% |